HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Martin L Yarmush Selected Research

Infections

3/2016Eradication of multidrug-resistant pseudomonas biofilm with pulsed electric fields.
4/2011Enhancement of naringenin bioavailability by complexation with hydroxypropyl-β-cyclodextrin. [corrected].
1/2011The inflammatory response to double stranded DNA in endothelial cells is mediated by NFκB and TNFα.
2/2006Liver endothelial cells promote LDL-R expression and the uptake of HCV-like particles in primary rat and human hepatocytes.
8/2005Identification of neutrophil gelatinase-associated lipocalin (NGAL) as a discriminatory marker of the hepatocyte-secreted protein response to IL-1beta: a proteomic analysis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Martin L Yarmush Research Topics

Disease

30Burns
07/2023 - 11/2002
23Wounds and Injuries (Trauma)
07/2023 - 11/2002
16Inflammation (Inflammations)
03/2024 - 08/2002
14Neoplasms (Cancer)
11/2023 - 08/2003
11Liver Failure
10/2013 - 01/2002
11Acute Liver Failure (Fulminant Hepatic Failure)
01/2012 - 01/2002
8Fatty Liver
01/2024 - 02/2004
6Liver Diseases (Liver Disease)
05/2022 - 04/2004
6Cicatrix (Scar)
01/2022 - 01/2015
5Infections
03/2016 - 08/2005
4Fibrosis (Cirrhosis)
02/2022 - 01/2007
4Ischemia
01/2020 - 01/2010
4Hepatocellular Carcinoma (Hepatoma)
01/2020 - 07/2009
4Drug-Related Side Effects and Adverse Reactions
01/2020 - 01/2007
4Death (Near-Death Experience)
06/2012 - 01/2009
3Non-alcoholic Fatty Liver Disease
02/2022 - 07/2018
3Reperfusion Injury
01/2017 - 01/2007
3Type 2 Diabetes Mellitus (MODY)
01/2017 - 06/2011
3Thrombosis (Thrombus)
07/2015 - 01/2013
3Obesity
03/2015 - 08/2010
3Necrosis
01/2013 - 02/2004
2Hyperglycemia
01/2023 - 10/2021
2Carcinoma (Carcinomatosis)
02/2022 - 10/2019
2Hypoxia (Hypoxemia)
01/2020 - 03/2009
2Spinal Cord Injuries (Spinal Cord Injury)
01/2019 - 12/2015
2Mitochondrial Diseases (Mitochondrial Disease)
01/2019 - 03/2005
2Body Weight (Weight, Body)
09/2017 - 03/2015
2Weight Loss (Weight Reduction)
09/2017 - 01/2017
2Shock
01/2016 - 05/2014
2Myocardial Infarction
02/2013 - 05/2008
2Brain Death (Brain Dead)
04/2012 - 01/2011
2Acute Kidney Injury (Acute Renal Failure)
01/2012 - 05/2008
2Colitis
01/2012 - 03/2011
2Dyslipidemias (Dyslipidemia)
04/2011 - 08/2010
2Atherosclerosis
08/2010 - 02/2006
2Prostatic Neoplasms (Prostate Cancer)
07/2010 - 07/2007
2End Stage Liver Disease
01/2009 - 11/2004
2Sepsis (Septicemia)
05/2007 - 07/2006
2Pseudomonas Infections
10/2005 - 08/2004
2Acute-Phase Reaction
08/2005 - 06/2004

Drug/Important Bio-Agent (IBA)

15Proteins (Proteins, Gene)FDA Link
01/2023 - 06/2004
8Peptides (Polypeptides)IBA
01/2017 - 07/2006
8salicylhydroxamic acid (SHAM)IBA
04/2011 - 06/2004
7CollagenIBA
12/2018 - 02/2003
6LipidsIBA
01/2023 - 04/2009
5Adenosine Triphosphate (ATP)IBA
01/2023 - 08/2003
5LipopolysaccharidesIBA
01/2020 - 09/2004
4CytokinesIBA
02/2022 - 06/2004
4dicarboxydine (DCD)IBA
06/2012 - 01/2009
4NitrogenIBA
04/2011 - 08/2003
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2024 - 07/2009
3EnzymesIBA
01/2024 - 01/2016
3Nonesterified Fatty Acids (NEFA)IBA
10/2019 - 03/2009
3Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
10/2017 - 01/2011
3cibinetideIBA
10/2017 - 02/2013
3AlginatesIBA
06/2017 - 10/2015
3Glucose (Dextrose)FDA LinkGeneric
03/2015 - 02/2012
3DNA (Deoxyribonucleic Acid)IBA
09/2013 - 01/2005
3naringeninIBA
11/2011 - 08/2010
3Insulin (Novolin)FDA Link
08/2010 - 02/2003
3Interleukin-6 (Interleukin 6)IBA
08/2005 - 08/2002
2Elastin-Like PolypeptidesIBA
01/2023 - 01/2016
2Advanced Glycation End ProductsIBA
01/2023 - 10/2021
2Transcription Factors (Transcription Factor)IBA
02/2022 - 01/2007
2Oxygen (Dioxygen)IBA
01/2020 - 10/2019
2Reactive Oxygen Species (Oxygen Radicals)IBA
01/2020 - 08/2014
2Fatty Acids (Saturated Fatty Acids)IBA
10/2019 - 01/2016
2Gap Junction beta-1 ProteinIBA
07/2018 - 01/2012
2ConnexinsIBA
07/2018 - 01/2012
2ElastinIBA
01/2017 - 01/2011
2Acetaminophen (Paracetamol)FDA LinkGeneric
03/2016 - 01/2012
2PolymersIBA
01/2016 - 01/2013
2Lactic Acid (Lactate)FDA LinkGeneric
10/2015 - 08/2005
2Triglycerides (Triacylglycerol)IBA
08/2014 - 03/2009
2AntigensIBA
01/2013 - 07/2007
2Peroxisome Proliferator-Activated Receptors (PPAR)IBA
11/2011 - 06/2011
2CarbonIBA
04/2011 - 03/2005
2Urea (Carbamide)FDA LinkGeneric
04/2011 - 08/2003
2IceIBA
06/2009 - 06/2008
2Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
01/2007 - 05/2006
2Serum Amyloid A Protein (Serum Amyloid A)IBA
10/2005 - 09/2004
2Interleukin-1beta (Interleukin 1 beta)IBA
08/2005 - 08/2002
2Glutamine (L-Glutamine)FDA Link
08/2005 - 12/2004
2GalactosamineIBA
03/2005 - 04/2004
2Blood Proteins (Serum Proteins)IBA
09/2004 - 06/2004
2PlacebosIBA
08/2004 - 11/2002
2Interferon-gamma (Interferon, gamma)IBA
06/2004 - 11/2002
1Interleukin-1 (Interleukin 1)IBA
03/2024
1Dexamethasone (Maxidex)FDA LinkGeneric
03/2024

Therapy/Procedure

25Therapeutics
01/2022 - 01/2002
12Liver Transplantation
05/2022 - 01/2002
11Transplantation
10/2019 - 02/2004
10Artificial Liver (Bioartificial Liver)
06/2014 - 01/2002
3Gastric Bypass (Roux-en-Y Gastric Bypass)
09/2017 - 07/2013
3Bariatric Surgery
09/2017 - 03/2015
3Microspheres (Microsphere)
06/2017 - 10/2015
2Debridement
07/2023 - 02/2013
2Lasers (Laser)
12/2014 - 03/2009
2Punctures
05/2007 - 07/2006
2Ligation
05/2007 - 07/2006